Position in DNLI
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,009,921
+$1,472,360 QoQ
Shares Held
194,787
+5.7% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 18%
Shared 0%
None 82%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. DNLI ranks #49 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in DNLI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,009,921 | 194,787 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,537,561 | 184,248 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,021,330 | 183,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,926,723 | 201,565 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,972,916 | 212,503 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,586,530 | 190,256 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $3,880,148 | 190,390 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $5,531,583 | 189,893 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,524,625 | 194,859 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $3,528,598 | 171,959 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,578,733 | 166,763 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $3,489,028 | 169,124 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $4,780,088 | 161,982 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $3,367,111 | 146,142 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,974,938 | 142,932 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,926,263 | 127,933 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,457,289 | 117,475 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,125,154 | 97,145 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $4,310,545 | 96,649 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,914,082 | 97,405 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,440,426 | 94,855 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $4,086,932 | 71,575 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $6,669,222 | 79,623 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,833,973 | 79,095 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,198,324 | 90,915 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,154,434 | 65,930 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||